Endologix (ELGX)

Add to Watchlists
Create an Alert
11.97 -0.06  -0.50% NASDAQ Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
ELGX Price Chart
View All Events

ELGX Events

Date Type Description
Feb 27 Misc Endologix, Inc. Q4 2013 Earnings Conference Call
Feb 27 Earnings Endologix, Inc. Q4 2013 Earnings Results. Estimate: -0.04.
Nov 20 Misc Endologix Investor Meeting
Oct 30 Misc Endologix Announcesthird Quarter 2013 Financial Call
Oct 30 Earnings Endologix to Report Third Quarter 2013 Financial Results on October 30, 2013. Estimate: -0.05.
Jul 01 Misc Endologix Q2 2013 Conference Call
Jul 01 Earnings Endologix Announces Preliminary Second Quarter 2013 Revenue Growth of 33% and Update to Ventana Program. Estimate: -0.05.
May 23 Misc AGM Event for Endologix Inc
Apr 30 Misc Endologix, Inc. First Quarter Earnings Conference Call
Apr 30 Earnings Endologix to Report First Quarter 2013 Financial Results on April 30, 2013. Estimate: -0.04.
View All Performance Charts

ELGX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Endologix is down 19.39% over the last year vs S&P 500 Total Return up 21.54%, Terumo down 15.08%, and CR Bard up 38.40%.

Get Quote for

PDF Report for ELGX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ELGX Pro Report PDF

Portfolio Strategies Featuring ELGX

Did Endologix make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ELGX Profile

  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Surgical and Medical Instrument Manufacturing
  • NAICS Code: 339112
  • NAICS Industry: Medical Equipment and Supplies Manufacturing
  • NAICS Industry Code: 3391
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of Abdominal Aortic Aneurysms (AAA). The firm currently marketing Powerlink Delivery System an innovative, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. The company was founded in March 1992 and is headquartered in Irvine, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ELGX 11.97 -0.06 -0.50% 764.51M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.